Search Results for: Positive Results for Alkermes Phase
Articles
November 8, 2016
Positive Results for Alkermes' Phase III Study Spell Good News for Major Depressive Disorder Space November 8, 2016
Positive topline results have been announced by Alkermes for its Phase III study of ALKS-5461 as an adjunctive therapy for...
March 31, 2013
SPECIAL REPORT - Outsourcing Formulation Development and Manufacturing: An Early Approach Saves Time and Money March 31, 2013
In this Special Report, Contributor Cindy H. Dubin asks many of the leading companies in this sector what challenges pharma currently faces in formulation and manufacturing and how they, as third-party providers, are helping to alleviate those burdens.
